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Abstract
Human clonorchiasis has been increasingly prevalent in recent years and results in a threat to the public health in epidemic
regions, motivating current strategies of vaccines to combat Clonorchis sinensis (C. sinensis). In this study, we identified C.
sinensis paramyosin (CsPmy) from the cyst wall proteins of metacercariae by proteomic approaches and characterized the
expressed recombinant pET-26b-CsPmy protein (101 kDa). Bioinformatics analysis indicated that full-length sequences of
paramyosin are conserved in helminthes and numerous B-cell/T-cell epitopes were predicted in amino acid sequence of
CsPmy. Western blot analysis showed that CsPmy was expressed at four life stages of C. sinensis, both cyst wall proteins and
soluble tegumental components could be probed by anti-CsPmy serum. Moreover, immunolocalization results revealed that
CsPmy was specifically localized at cyst wall and excretory bladder of metacercaria, as well as the tegument, oral sucker and
vitellarium of adult worm. Both immunoblot and immunolocalization results demonstrated that CsPmy was highly
expressed at the stage of adult worm, metacercariae and cercaria, which could be supported by real-time PCR analysis. Both
recombinant protein and nucleic acid of CsPmy showed strong immunogenicity in rats and induced combined Th1/Th2
immune responses, which were reflected by continuous high level of antibody titers and increased level of IgG1/IgG2a
subtypes in serum. In vaccine trials, comparing with control groups, both CsPmy protein and DNA vaccine exhibited
protective effect with significant worm reduction rate of 54.3% (p,0.05) and 36.1% (p,0.05), respectively. In consistence
with immune responses in sera, elevated level of cytokines IFN-c and IL-4 in splenocytes suggested that CsPmy could induce
combined cellular immunity and humoral immunity in host. Taken together, CsPmy could be a promising vaccine candidate
in the prevention of C. sinensis regarding its high immunogenicity and surface localization.
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Introduction
Human clonorchiasis, caused by the liver fluke Clonorchis sinensis
(C. sinensis), has been increasingly prevalent in recent years,
resulted from greater consumption of raw freshwater fish
containing infective C. sinensis metacercariae [1]. Including 15
million afflicted people in China, more than 35 million people
globally were infected by this food-borne parasite [2,3]. Current
evidences from experimental and epidemiological investigations
have confirmed the association between C. sinensis and cholangio-
carcinoma [4,5,6]. Moreover, chronic infection by the carcino-
genic parasite has been regarded to be responsible for other
hepatobiliary diseases such as pyogenic cholangitis, cholelithiasis,
cholecystitis and hepatic fibrosis [7]. Increasing infection of C.
sinensis has led to negative socio-economic impact in epidemic
regions and resulted in a threat to the public health. Nonetheless,
the complicated molecular mechanism involved in liver fluke-
associated hepatobiliary diseases remains to be elucidated,
motivating current strategies of vaccines to combat C. sinensis [8].
The increasing power of mass spectrometry and proteomics of
food-borne trematodes has facilitated to directly identify important
molecules as vaccine candidates [9]. Compared with secreted
proteins and other components of the parasites, tegumental
proteins are more important in nutrition ingestion, immune
evasion and host-parasite interaction [10,11]. For instance,
tegumental proteins of schistosome have recently been character-
ized by proteomic approaches and experimental trials, suggesting
novel vaccine candidates for combating human blood flukes
[12,13,14]. Surface proteomes of Opisthorchis viverrini also provided
a subset of proteins critical for liver fluke survival as well as the
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information was known about the tegumental proteins of C.
sinensis, especially the properties of cyst wall proteins of
metacercariae that were crucial in protecting juveniles from being
injured by external environment [16]. Here we performed
proteomic-based identification and characterization of cyst wall
proteins, of which paramyosin was one of the abundant
component. Paramyosin has been demonstrated as a myofibrillar
protein present in numerous invertebrates including helminth
parasites [17,18]. Moreover, previously studies indicated that
paramyosin was a multifunctional molecule that involved in both
muscle physiological contraction and immunoregulation [19]. As
an immunogenic vaccine candidate, paramyosin has been
investigated for the protective effect in various of parasites
including Schistosoma japonicum [20,21], Schistosoma mansoni [22],
Taenia solium [23] and Echinococcus granulosus [24]. Results from
vaccine trails made paramyosin a promising vaccine candidate
against C. sinensis infection.
In the present study, we identified and characterized para-
myosin from the cyst wall of C. sinensis metacercariae by proteomic
approaches. Both immunoblot and immunolocalization results
validated that paramyosin was the component of cyst wall
proteins. Results from vaccine trails showed that paramyosin
had high immunogenicity and conferred protective effect against
C. sinensis infection, making C. sinensis paramyosin (CsPmy) as a
promising vaccine candidate in the control of C. sinensis.
Materials and Methods
Parasites and animals
C. sinensis metacercariae and C. sinensis cercarie were isolated
from experimentally infected freshwater fish Ctenopharyngodon idellus
(C. idellus) and freshwater snails Parafossarulus striatulus (P. striatulus)
in our laboratory pool [25]. C. sinensis adult worms were recovered
from infected livers of Sprague-Dawley (SD) rats, which were
purchased from animal center of Sun Yat-sen University and
raised carefully in accordance with National Institutes of Health
on animal care and the ethical guidelines. All experimental
procedures were approved by the Animal Care And Use
Committee of Sun Yat-sen University (Permit Numbers:
SCXK(Guangdong) 2009-0011).
In vitro excystation of C. sinensis metacercariae for cyst
wall proteins
Briefly, 10,000 C. sinensis metacercariae were isolated from
experimentally infected freshwater fish C. idellus by digesting the
fish muscle with artificial gastric juice (0.2% HCl, 0.6% pepsin,
pH 2.0) at 37uC for 2 h. Viability and integrity of metacercariae
were assessed under microscope (6100). 0.001% trypsin (Promega,
Wisconsin,USA) in physiological saline was employed as excysta-
tion stimulus in vitro. After activation, cyst wall of metacercariae
was immediately collected in RIPA lysis buffer (Amresco, Solon,
USA), added with 1 mM Phenylmethanesulfonyl fluoride (PMSF,
Sigma, St. Louis, USA). The cyst wall was placed on ice in RIPA
lysis buffer and then subjected to centrifugation at 8,000 g at 4uC
for 15 min to remove the sediment, 4-fold cold acetone
(containing 0.07% b-mercaptoethanol) was added to the superna-
tant and stored at 220uC overnight. Subsequently, repeated the
washing procedures with 4-fold cold acetone and removed the
supernatant after centrifugation, then the sediment was treated
with 16loading buffer (50 mM Tris, 2% SDS, pH 6.8) to get cyst
wall proteins which were subjected to sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE, 8% gel) followed
by Coomassie Blue staining.
Proteomic identification of C. sinensis metacercariae cyst
wallproteins by high performance liquidchromatography-
tandem mass spectrometry (HPLC-MS/MS)
Gel lanes in SDS-PAGE to be analyzed were excised, about ten
visible gel sections were separated and divided into small pieces, all
pieces were washed in sterile water and completely destained using
destaining solution (25 mM ammonium bicarbonate, 50% aceto-
nitrile). Subsequently, trypsin digestion was performed as described
[26]. The reduction step was performed by adding 100 mLo f
10 mM DTT (25 mM ammonium bicarbonate) into the samples
and incubating at 37uC for 3 h. Protein alkylation was done by
adding 100 mL of 55 mM iodoacetamide (25 mM ammonium
bicarbonate) and reacted in the dark at 20uC for 30 min. Gel pieces
were then treated with 50% acetonitrile and digested with 0.02 mg/
ml sequencing grade modified trypsin (Promega) at 37uC overnight.
The peptides were then extracted with extraction buffer (67%
acetonitrile, 2.5% trifluoroacetic acid) and completely dried in a
SpeedVac centrifuge (Thermo Fisher Scientific, Waltham, USA).
Dried peptides were analyzed with a Finnigan Surveyor HPLC
system coupled online with LTQ-Oribitrap XL (Thermo Fisher
Scientific) equipped with a nanospray source. HPLC-MS/MS
experiment was carried out at the Institute of Life and Health
Engineering and National Engineering Research Center of Genetic
Medicine at Jinan University in China. Bioinformatics analysis was
performed by inputting the amino acids into the Protein
Information Resource (http://pir.georgetown.edu/cgi-bin/batch.
pl) and NCBI Database (http://www.ncbi.nlm.nih.gov/). Identified
peptides were annotated with predicted names and listed with
corresponding database accession numbers.
Bioinformatics analysis of CsPmy. We found three genes
(clone numbers: Cs020c02/Cs032a06/Cs046e06) annotated with
paramyosin in our C. sinensis metacercaria cDNA plasmid library by
searching the keyword ‘paramyosin’. We sequenced the
corresponding plasmids to get the full-length complete encoding
sequence of CsPmy and then analyzed the nucleotide sequence with
BLASTx. The open reading frame (ORF) was found with ORF
finder tool in NCBI database (http://www.ncbi.nlm.nih.gov/).
Sequence alignment was done by comparing the amino acid
sequence of pamamyosin from our laboratory (C. s-1, JQ041818)
with that of other helminthes including C. sinensis from Korea
laboratory (C. s-2, ABN79674.1), Paragonimus westermani (P. w,
AAY44740.1), Schistosoma haematobium (S. h, BAF62291.1), Schistosoma
japonicum (S. j, AAA81003.1), Schistosoma mansoni (S. m, AAA29915.1),
Taenia solium (T. s, AAK58494.1) and Echinococcus granulosus (E. g,
CAA79849.1)usingsoftwareVectorNTIsuite8.0.Physicochemical
properties and conserved domains were predicted with Proteomics
tools in ExPaSy web site (http://www.expasy.org/). Both B-cell and
T-cell linear epitopes were analyzed by the tools at http://www.cbs.
dtu.dk/services/. Nucleotide and amino acid sequences described
in the present study have been submitted to GenBank database
under the accession number JQ041818.
Recombinant plasmid construction and purification of
CsPmy protein
The ORF of CsPmy was amplified by polymerase chain reaction
(PCR) from the recombinant plasmid of cDNA library. Specific
PCR primers used in the present study were listed in Table S1.
The PCR products were purified and firstly cloned into PMD19-T
clone vector, and subsequently transformed into E. coli DH5a cells.
After sequencing, the recombinant plasmid DNA was digested
with corresponding restriction enzymes and then the ORF of
CsPmy was subcloned to expression plasmids including prokary-
otic expression vector His6 tag pET-26b(+) (Qiagen, California,
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TM-3.1(+), respec-
tively. The expression of the recombinant fusion protein (pET-
26b-CsPmy) in E. coli BL21 (DE3) was induced by isopropy-b-D-
thiogalactoside (IPTG) at a final concentration of 1 mM at 37uC
for 5 h in Luria-Bertani medium (containing 50 mg/ml kanamy-
cin). Lysate of E. coli with pET-26b-CsPmy was collected after
centrifugation and treated with ultrasonication to separate the
supernatant and sediment. The sediment containing the recom-
binant fusion protein was washed with Washing buffer (50 mM
Tris-HCl, 50 mM NaCl, 1 mM EDTA, 1% Triton X-100, 2 M-
urea, pH 8.0) and dissolved with Dissolved buffer (50 mM Tris-
HCl, 50 mM NaCl, 1 mM EDTA, 1% Triton X-100, 6 M-urea,
pH 8.0) followed by centrifugation. Subsequently, the supernatant
was gradiently treated with 5–200 mM imidazole (containing
6 M-urea). After Ni-NTA affinity chromatograph, the purified
protein was renatured by gradient-urea dialysis from 4 M to 0 M.
Finally, the renatured protein was dialyzed in phosphate buffer
saline (PBS), the purity and concentration of pET-26b-CsPmy
were analyzed by 8% SDS-PAGE followed by Coomassie blue
staining. Recombinant pcDNA-CsPmy and empty pcDNA
plasmids (in PBS) were isolated from E. coli DH5a and the
A260/A280 ratio was measured spectrophotometrically for quality
determination. The purified recombinant protein and plasmids
were stored at 280uC for use.
Preparation for total worm extracts (TWE), soluble
tegumental components and the antiserum of
recombinant CsPmy protein
Briefly, adult worms, metacercariae, cercariae and eggs were
crushed to prepare the TWE with the lysis buffer containing 1 mM
PMSF (Sigma), the Bradford assay was used to determine the final
concentration of TWE. Soluble tegumental components of adult
worm were obtained by ProteoExtract Native Membrane Protein
Extraction kit (Merck KGaA, Darmstadt, Germany) with the
methods previously described [7]. Recombinant pET-26b-CsPmy
was emulsified with complete Freund’s adjuvant and subcutane-
ously injected to SD rats, each animal was given 200 mg
recombinant protein for the first injection, and 100 mg recombinant
protein emulsified with incomplete Freund’s adjuvant was given for
the next two boosters at 2-week interval. The rat sera were collected
2 weeks post the last injection and stored at 280uC for use.
Identification of CsPmy by SDS-PAGE and Western blot
analysis
The recombinant pET-26b-CsPmy (2 mg/lane), TWE of four life
stages (adult worm, metacercaria, cercaria and egg, 10 mg/lane)
wereresolvedby8%SDS-PAGEandthenimmobilizedontoPVDF
membrane. At the same time, cyst wall proteins of metacercaria and
soluble tegumental components of adult worm were also immobi-
lized onto PVDF membrane. The membrane was blocked with 5%
(w/v) skim milk at 4uC overnight, and then incubated with anti-
pET-26b-CsPmy rat serum and naı ¨ve rat serum (1:2000 dilutions in
1% BSA-PBS) at room temperature for 2 h after the washing
procedure. Subsequently, the membrane was followed by incuba-
tion with rabbit anti-rat IgG HRP-conjugated secondary antibody
(1:2000 dilutions in 1% BSA-PBS, Proteintech Group, Chicago,
USA) at room temperature for 1 h. The protein bands were
visualized by enhanced chemiluminescence (ECL) method.
Transcriptional level of CsPmy at different developmental
stages by real-time quantitative PCR (qRT-PCR)
To investigate mRNA expression pattern of CsPmy at different
developmental stages of C. sinensis (adult worm, metacercaria,
cercaria and egg), we carried out qRT-PCR experiments among
the four stages. Total RNA from parasites of four stages were
extracted by TRIzol methods (Invitrogen, California, USA)
according to the manufacturer’s instructions and spectrophoto-
metrically quantitated. Reverse transcription reactions were
carried out to get the first-strand cDNA using RT-PCR Kit
(TaKaRa, Dalian, PR China) with the same quantity of total RNA
as the template (1 mg). b-actin of C. sinensis (accession number:
EU109284) was used as the transcription control. The primers for
Csb-actin amplification were listed in Table S1 and confirmed that
they were optimized for amplification efficiency in qRT-PCR
experiments. The real-time PCR amplification was performed
using the LightCycler480 instrument (Roche, Switzerland) using
the SYBR Premix ExTaq Kit (TaKaRa). The PCR amplification
program was 95uC for 30 sec, followed by 40 cycles of 95uC for
5 sec and 60uC for 20 sec. The melting curve was performed using
a program of 95uC for 30 sec and 65uC for 15 sec. The
LightCycler480 software (version 1.5) was used to analyze the
data according to the 2
2DDCt method [27]. The transcript of egg
was employed as the calibrator to evaluate relative expression
levels of CsPmy.
Immunohistochemical localization of CsPmy at adult
worm and metacercaria
Adult worms and metacercariae of C. sinensis were fixed with 4%
paraformaldehyde, embedded with paraffin and sliced into 3–
5 mm in thick. All sections were dewaxed with dimethylbenzene
and treated with 100%, 95%, 85%, and 75% alcohol, respectively.
The sections were blocked with normal goat serum overnight at
4uC, and then incubated with anti-pET-26b-CsPmy rat serum and
naı ¨ve rat serum at room temperature for 2 h, the serum was
diluted at 1:200 for all sections. After washing three times with
PBST (containing 0.1% Tween-20), the sections were incubated
with goat anti-rat IgG (1:400 dilutions in 0.1% BSA-PBST, Alexa
Fluor 594, Molecular Probes, California, USA) at room temper-
ature for 1 h in dark and imaged under fluorescence microscope
(ZEISS, Goettingen, Germany).
Vaccination protocols
To explore the protection efficacy of CsPmy against C. sinensis
infection, we carried out the preliminary vaccination experiments
in rats. Thirty two six-week-aged Sprague Dawley rats were
randomly divided into four groups as pET-26b-CsPmy group, PBS
group, pcDNA-CsPmy group, and pcDNA group, each of which
consisted of eight rats. Generally, 200 mg/per rat of recombinant
pET-26b-CsPmy or equivalent volume PBS was subcutaneouly
injected with Freund’s adjuvant at week 0, week 2, and week 4.
200 mg/per rat of pcDNA-CsPmy or pcDNA plasmid was injected
intramuscularly in quadriceps in the same frequency. All rats were
kept under the same conditions until sacrificed, the protection
experiments in the present study were carried out blindly.
Antibody titers and IgG isotype measurement
In order to analyze the immune responses to CsPmy, we
measured the antibody titers of total IgG in immunized sera by
enzyme linked immunosorbent assay (ELISA). Briefly, 1 mg/well
recombinant pET-26b-CsPmy protein was coated with coating
buffer (0.05 M carbonate-bicarbonate, pH 9.6) and blocked with
5% skimmed milk. After washing procedure, the plate was
incubated with different dilutions of the immune sera (week 6)
raised by pET-26b-CsPmy and pcDNA-CsPmy. Rat sera immu-
nized with PBS and pcDNA were measured under the same
conditions as negative controls. Subsequently, HRP-conjugated
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33703IgG (1:20000 dilutions in 0.1% BSA-PBST, Proteintech Group)
was used as the secondary antibodies. After 1 h incubation the
plate was washed three times with PBST and the reactions were
developed by adding 100 ml substrate solution 3, 39,5 ,5 9-
Tetramethylbenzidine (TMB, BD biosciences, San Diego, USA).
After 5 min incubation in dark, reactions were stopped by adding
50 ml2MH 2SO4 and absorbance was measured at 450 nm.
After measuring the antibody titer, to investigate the tendency of
circulation antibodies and the profiles of immune responses, we
tested the level of total IgG and IgG isotype by diluting the sera
(week 2, 4, 6) at 1:400. IgG (1:20000 dilutions), IgG1 and IgG2a
(1:1000 dilutions in 0.1% BSA-PBST, Bethyl, Texas, USA) were
employed as secondary antibodies.
Evaluation of vaccine efficacy against challenge
After the measurement of antibody titers at week 6 post
immunization, remaining rats (n=6 for each group) were
anesthetized with ether and challenged with 100 living C. sinensis
metacercariae by intragastric administration.
The previously described egg counting method [28] was
employed to calculate eggs per gram feces (EPG) from weeks 4
post challenge infection. The experimental rats were sacrificed at
week 6 post infection to recover adult worms from livers for worm
burden evaluation. Reduction rates in parasite burden were
calculated as follows. Worm reduction rate (%)=[(average worm
burden of control group–average worm burden of experimental
group)/average worm burden of control group]6100%. Egg
reduction rate (%)=[(average EPG of control group–average EPG
of experimental group)/average EPG of control group]6100%.
Statistics and software
SPSS version 16.0 software was used in the present study for all
statistical analysis. Results for analysis represented mean 6 S.D.,
the recovered worm numbers and EPG in groups were compared
by Student’s t-test, and p value of ,0.05 was considered significant
difference.
Results
Microscopical examination of parasites and cyst wall
proteins
Under the microscope, C. sinensis metacercariae presented
round-shaped appearance with intact cyst wall, with the juveniles
inside (Figure 1A). In vitro excystation of C. sinensis metacercariae
was performed by adding 0.001% trypsin to the medium. After
activation, most of juveniles immediately moved out (Figure 1B),
remaining only the cyst wall (Figure 1C). 500 mg proteins were
routinely processed for HPLC-MS/MS. Molecular mass of cyst
wall proteins ranged from 11 kDa to 150 kDa (see Table 1).
Protein peptides were bioinformatics analyzed, yielding nine
proteins with contaminations excluded (see Table 1). Among the
matched peptides, paramyosin got high score in match results,
with a description of muscle component. The remaining matched
proteins were related to protein-protein interactions, motor
activity, protein binding, collagen superfamily, cell-surface recep-
tor, and membrane component, respectively. In general, the
identified cyst wall proteins could be classified as structural
proteins and interaction proteins based on their biological
functions.
Isolating and sequence analysis of CsPmy sequence
Three genes annotated with ‘paramyosin’ were isolated from
our C. sinensis metacercaria cDNA plasmid library, we got the full-
length complete encoding sequence of CsPmy (3465 bp) with an
ORF of CsPmy contained 2595 bp encoding 864 aa (see Figure
S1). After comparing the CsPmy sequences from our metacercaria
cDNA library (C. s-1) with the sequences submitted by the
laboratory from Korea (C. s-2), we found that six base pairs and
four amino acids were different between nucleotide sequences and
amino acid sequences, respectively. However, five identified
peptides in HPLC-MS/MS results were all matched with amino
acid sequences both in C. s-1 and C. s-2 with the protein coverage
of 6.5% (see Figure S1). Sequence alignment showed that amino
acid sequence paramyosin are conserved in helminthes including
C. s-1, C. s-2, Paragonimus westermani, Schistosoma haematobium,
Schistosoma japonicum, Schistosoma mansoni, Taenia solium and Echino-
coccus granulosus (Figure 2) with the identity of 74–99%. 29 B-cell
and 15 T-cell linear epitopes were predicted in amino acid
sequence of CsPmy, implying high immunogenicity of this
molecule. Bioinformatics analysis showed the predicted molecular
mass of recombinant pET-26b-CsPmy was 101.097 kDa and
theoretical isoelectric point was 5.51. The conserved domain of
myosin tail was localized at 22 aa-841 aa while no signal peptide or
transmembrane region was found in amino acid sequence of
CsPmy.
Cloning, expression and purification of CsPmy protein
The recombinant pET-26b-CsPmy protein was overexpressed
as inclusion bodies in E. coli BL21 (DE3) with a molecular mass
around 100 kDa (Figure 3A, lane 4 and 6). The inclusion bodies
could be abundantly dissolved with 6 M urea (Figure 3B, lane 2)
and eluted with 200 mM imidazole in high purity. After gradient
renaturation and concentration, the purified pET-26b-CsPmy
protein was collected (Figure 4A, lane 1). A260/A280 ratio
(1.85,1.9) of pcDNA-CsPmy and pcDNA plasmids confirmed the
high quality of isolated plasmids.
Figure 1. Microscopical examination of C. sinensis metacercariae for cyst wall proteins. (A) Intact metacercaria (6400); (B) Excysted
juvenile, juvenile immediately moved out (6100); (C) Cyst wall (6400). Bar=0.1 mm.
doi:10.1371/journal.pone.0033703.g001
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Anti-pET-26b-CsPmy rat serum was used to probe recombinant
CsPmy (Figure 4B, lane 1), TWE of adult worms (Figure 4B, lane
2), TWE of metacercariae (Figure 4B, lane 3), TWE of cercariae
(Figure 4B, lane 4) and TWE of eggs (Figure 4B, lane 5). The
expression level of CsPmy at adult worm and metacercaria were
higher than that of cercaria and egg. Moreover, HPLC-MS/MS
results were validated by Western blot analysis, cyst wall proteins
of metacercariae (Figure 4B, lane 6), and soluble tegumental
components of adult worms (Figure 4B, lane 7) could be probed by
antiserum. In SDS-PAGE, molecular mass of cyst wall proteins
were similar to that of the highly expressed proteins in
metacercariae, indicating that CsPmy may be an important
component of the cyst wall proteins in metacercariae (Figure 4B,
lane 3).
Transcriptional level of CsPmy at different developmental
stages
To analyze mRNA expression pattern of CsPmy in four
developmental stages of C. sinensis including adult worm,
metacercaria, cercaria and egg, we carried out qRT-PCR
experiments with corresponding cDNA generated from total
RNA. The results of qRT-PCR demonstrated CsPmy were
expressed at the four examined stages (Figure 5). Normalized
with C. sinensis b-actin, CsPmy transcribed highly at the stage of
adult worm, metacercaria and cercaria while the expression level
at egg was relatively low. Western blot analysis suggested CsPmy
was translated among the four life stages with progressively
increased expression level, which was accordance with qRT-PCR
results (Figure 4B).
Immunohistochemical localization of CsPmy at adult
worm and metacercaria
In immunofluorescence assay (IFA), CsPmy was specifically
localized at the tegument, oral sucker and vitellarium of adult
worm (Figure 6, panel A and E). With the same dilution of anti-
pET-26b-CsPmy rat serum, CsPmy was highly expressed at cyst
wall and excretory bladder of metacercaria (Figure 6, panel I).
While no specific fluorescence was detected in sections treated
with naı ¨ve serum (Figure 6, panel C, G and K). Together, both
IFA assay and above-mentioned immunoblot results confirmed the
localization of CsPmy at the tegument of C. sinensis.
Immune responses to CsPmy
As shown in Figure 7, we measured the antibody titers of total
IgG in immunized sera of pET-26b-CsPmy group and pcDNA-
CsPmy group. Antibody titers in the two groups peaked to
1:204800 (Figure 7A) and 1:102400 (Figure 7B), respectively,
showing the high immunogenicity of CsPmy. After the first
injection, serum level of IgG ascended rapidly both in pET-26b-
CsPmy group (Figure 8A) and pcDNA-CsPmy group (Figure 8B).
Additionally, we explored the Th1/Th2 type immune responses to
CsPmy by measuring IgG1 and IgG2a from week 2 to week 6 post
immunization (Figure 8). The ELISA results showed that
combined Th1/Th2 immune responses were provoked by both
pET-26b-CsPmy (Figure 8A) and pcDNA-CsPmy (Figure 8B) for
both IgG1 and IgG2a level increased from week 2 to week 6. The
increased IgG isotype demonstrated that combined cellular
immunity and humoral immunity had been successfully induced
by CsPmy.
Protective effect of CsPmy in vaccination trials
The protective effect was assessed by comparing the worm
burden and EPG among experimental groups. EPG was
calculated three times from four weeks post challenge infection,
all rats in four groups were sacrificed six weeks post infection. In
Table 2, average worm numbers in pET-26b-CsPmy group (n=6),
PBS group (n=6), pcDNA-CsPmy group (n=6) and pcDNA group
(n=6) were 12.7, 27.8, 16.3, and 25.5, respectively. Average EPG
in four groups was 1833.3, 3733.3, 2733.3, and 4466.7,
respectively. Worm numbers and EPG in PBS group were
significantly higher than those in pET-26b-CsPmy group
(p,0.01, t=9.524; p,0.01, t=13.392). Meanwhile, worm num-
bers and EPG in pcDNA group were also significantly higher than
those in pcDNA-CsPmy group (p,0.01, t=13.216; p,0.01,
t=6.874). Worm reduction rate in pET-26b-CsPmy group and
pcDNA-CsPmy group was 54.3% and 36.1%, respectively. The
corresponding egg reduction rate was 50.9% and 38.8%,
respectively. Comparing with the control groups, both pET-26b-
CsPmy and pcDNA-CsPmy effectively lessened worm burden and
EPG (see Table 2).
Discussion
The impact on public health of food-borne clonorchiasis is
considerable since more than 35 million people are infected with
C. sinensis and 601 million are at the risk of this neglected
Table 1. Proteins from cyst wall of C. sinensis metacercariae identified by HPLC-MS/MS.
Prot_acc Prot description Species Prot_score Prot_match Prot_cover Prot_mass
gi|238658811 paramyosin Schistosoma mansoni 92 6 1.7 131,296
gi|14324125 paramyosin Taenia solium 92 6 4.8 98,840
gi|126116628 paramyosin Clonorchis sinensis 87 17 6.5 99,452
gi|238660770 expressed protein Schistosoma mansoni 60 240 1.5 150,394
gi|156600431 myosin heavy chain Clonorchis sinensis 50 3 8.5 44,118
gi|76154067 SJCHGC06106 protein Schistosoma mansoni 40 5 2.1 50,610
gi|76155574 SJCHGC08294 protein Schistosoma mansoni 27 2 10.2 11,337
gi|256080653 titin Schistosoma mansoni 26 37 3.4 69,682
gi|227284694 stomatin-related Schistosoma mansoni 22 4 1.3 108,702
Prot_acc, protein accession number in databases; Prot description, the most likely matched protein name in the NCBI database. Prot_score, the similarity that peptide
matched in the NCBI database. prot_match, the matched peptides in the NCBI database. Prot_cover, the percent of identified amino acids in target amino acid
sequence. Prot_mass, molecular mass of matched proteins. Score .50 indicates extensive similarity (p,0.05) in the NCBI database.
doi:10.1371/journal.pone.0033703.t001
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33703Figure 2. Multiple sequence alignment of deduced amino acid sequence of paramyosin among helminthes. C. s-1 (JQ041818)
represents the sequence from our C. sinensis metacercaria cDNA plasmid library. C. s-2 (ABN79674.1) represents the sequence submitted by the
laboratory from Korea. Paragonimus westermani (P. w, AAY44740.1), Schistosoma haematobium (S. h, BAF62291.1), Schistosoma japonicum (S. j,
AAA81003.1), Schistosoma mansoni (S. m, AAA29915.1), Taenia solium (T. s, AAK58494.1) and Echinococcus granulosus (E. g, CAA79849.1). Amino acids
shared among helminthes were indicated in black, high conserved amino acids among helminthes were indicated in gray. B-cell and T-cell linear
epitopes were indicated with full lines and dotted lines, respectively.
doi:10.1371/journal.pone.0033703.g002
Paramyosin Expresses on Metacercariae Cyst Wall
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33703food-borne disease, which has been highly taken into account in
regarding its serious complications [29]. Like other food-borne
trematodes, vaccines and drugs are the two main interventions
currently before the definite pathogenic mechanism are illuminat-
ed [9,30]. The pressing demand for the development of novel
vaccines of parasites relies on molecular and biological investiga-
tions on the crucial proteins, including serected and tegumental
molecules [12,15]. The present study explored the potential role of
C. sinensis paramyosin as a vaccine candidate, which was identified
from the cyst wall of C. sinensis metacercariae by HPLC-MS/MS.
Cyst wall proteins of metacercariae and soluble tegumental
components of adult worms were probed by anti-pET-26b-CsPmy
immunized serum. CsPmy was expressed at four examined life
stages and immunohistochemically localized at cyst wall and
excretory bladder of metacercaria, and the tegument, oral sucker
and vitellarium of adult worm. Immunoblot and immunolocali-
zation results were consistent with previous discoveries that
paramyosin was expressed on the tegument of C. sinensis
[17,18,31], and were in supportive of our HPLC-MS/MS results
that paramyosin was an important cyst wall protein of C. sinensis
metacercariae. The proteomic approaches have provided us
evidences of the specific localization and inspired us to further
vaccine trials with CsPmy.
Recombinant pET-26b-CsPmy protein showed strong immu-
nogenicity revealed by the rapidly increased IgG titer, which
maintained for a high level from week 2 to week 6. In common
with previous studies [32], we predicted 29 B-cell linear epitopes in
the amino sequence of CsPmy, high level of antibody production
may result from multiple B cell epitopes of paramyosin. DNA-
based vaccine technology is a promising new tool in the
development of vaccines to efficiently stimulate humoral (antibody)
and cellular (T cell) immune responses to protein antigens,
immunogenic proteins are expressed in in vivo transfected cells in
their native conformation with correct posttranslational modifica-
tions [33]. DNA-based vaccines have been shown to confer
immunity against different infectious diseases including parasitic
infections based on their potential in inducing cellular immune
responses [8,34,35]. Here, we investigated the protective efficacy
of recombinant pcDNA-CsPmy plasmid which carried the full-
length sequence of CsPmy. The strong immune responses elicited
by pcDNA-CsPmy plasmid suggested that antigenic peptides of
CsPmy were efficiently processed by antigen-presenting cells in vivo.
As a sequence, both rats immunized with pET-26b-CsPmy protein
and pcDNA-CsPmy plasmid exhibited strongly combined Th1/
Th2 immune responses, which could be reflected by increased
level of IgG1 and IgG2a in serum. We also evaluated immune
responses by measuring Th1/Th2-associated cytokines level
including IFN-c and IL-4 (see Figure S2), which represented
Th1 type and Th2 type immune responses [8,34,35]. Although
increased level of IL-4 was lower than the level of IFN-c in both
pET-26b-CsPmy group and pcDNA-CsPmy group treated with
TWE or rPmy, elevated IL-4 secretion was apparently induced by
CsPmy, indicating that CsPmy was capable to induce combined
cellular and humoral immunity (see Figure S2). To be expected,
long-lasting strong antibody production resulted in significant
reduction rate of worm burden and EPG in our preliminary
vaccination trials, showing the potential of CsPmy as a C. sinensis
vaccine.
Figure 3. Expression and purification of recombinant pET-26b-
CsPmy identified by 8% SDS-PAGE. (A) Expression of pET-26b-
CsPmy. Protein molecular weight marker (M), lysate of E. coli with pET-
26b(+) before induction with IPTG (lane 1) and after induction (lane 2),
lysate of E. coli with pET-26b-CsPmy before induction with IPTG (lane 3)
and after induction (lane 4), supernatant of induced E. coli with pET-
26b-CsPmy (lane 5) and sediment (lane 6). (B) Denaturation of inclusion
bodies containing pET-26b-CsPmy. Supernatant collected from inclu-
sion bodies dissolved in 2 M urea (lane 1) and 6 M urea (lane 2). (C)
Purification of pET-26b-CsPmy. Protein eluted with 40 mM imidazole
(lane 1–3), 80 mM imidazole (lane 4–8), 100 mM imidazole (lane 9–12),
200 mM imidazole (lane 13–14). Proteins were visualized by Coomassie
Blue staining, the protein bands were around 100 kDa.
doi:10.1371/journal.pone.0033703.g003
Figure 4. Identification of CsPmy by SDS-PAGE and Western
blot analysis. Protein molecular weight marker (M), purified pET-26b-
CsPmy protein (lane 1), TWE of adult worm (lane 2), TWE of metacercaria
(lane 3), TWE of cercaria (lane 4), TWE of egg (lane 5), cyst wall proteins
of metacercaria (lane 6), and soluble tegumental components of adult
worm (lane 7). (A) 8% SDS-PAGE. (B) Western blot analysis. Correspond-
ing proteins were subjected to 8% SDS-PAGE and immobilized onto the
membrane, then the membrane was incubated with anti-pET-26b-
CsPmy rat serum (1:2000 dilutions) at room temperature for 2 h.
Subsequently, the membrane was followed by incubation with rabbit
anti-rat IgG HRP-conjugated secondary antibody (1:2000 dilutions) at
room temperature for 1 h. 2 mg of purified pET-26b-CsPmy protein and
10 mg of TWE were loaded per lane. SDS-PAGE was visualized by
Coomassie Blues staining and the protein bands that might be native
paramyosin in different life stages were indicated with arrows. Western
blot was visualized by ECL method, the detected protein bands were
around 100 kDa.
doi:10.1371/journal.pone.0033703.g004
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33703Figure 5. Transcriptional level of CsPmy at different developmental stages of C. sinensis by qRT-PCR experiments. Total RNA from four
stages (adult worm, metacercaria, cercaria and egg) were extracted by TRIzol methods and spectrophotometrically quantitated. Reverse transcription
reactions were carried out to get the first-strand cDNA with the same quantity of total RNA as the template (1 mg). b-actin of C. sinensis (accession
number: EU109284) was used as the transcription control. The real-time PCR amplification was performed using the LightCycler480 instrument
(Roche, Switzerland) using the SYBR Premix ExTaq Kit. The LightCycler480 software (version 1.5) was used to analyze the data according to the 2
2DDCt
method [27]. The amplification of egg was employed as the calibrator to evaluate relative expression levels of CsPmy.
doi:10.1371/journal.pone.0033703.g005
Figure 6. Immunohistochemical localization of CsPmy at adult worm and metacercaria. Adult worms and metacercariae of C. sinensis were
fixed with 4% paraformaldehyde, embedded with paraffin and sliced into 3–5 mm in thick. The sections were blocked with normal goat serum
overnight at 4uC, and then incubated with primary antibody (1:200 dilutions) at room temperature for 2 h. After washing procedures, the sections
were incubated with goat anti-rat IgG Alexa Fluor 594 (1:400 dilutions) at room temperature for 1 h in dark. The images were captured under
fluorescence microscope (ZEISS, Goettingen, Germany). Panel A–H, adult worm of C. sinensis. Pane I–L, metacercariae of C. sinensis. Pane A, B, E, F, I
and J were sections treated with anti-pET26b-CsPmy serum. C, D, G, H, K and L were sections treated with naı ¨ve serum and imaged under the same
conditions. Specific immunofluorescence was indicated in red (pane A, E and I), while no immunofluorescence was detected in pane C, G and K.
Corresponding white light of parasite was panel B, D, F, H, J and L. T, tegument. OS, oral sucker. V, vitellarium. CW, cyst wall. EB, excretory bladder.
Magnification for adult worm and metacercaria were 6100 and 6400, respectively.
doi:10.1371/journal.pone.0033703.g006
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dynamic host-interactive layer involved in nutrition ingestion,
immune evasion, metabolin secretion, sensory reception and signal
transduction [10]. Also, cyst wall of C. sinensis covers the entire body
of metacercariae to protect juveniles from being attacked by
immune response of host. In the present study, proteomic analysis
enabled us to characterize the cyst wall proteins of C. sinensis,a sa
consequence, paramyosin was abundantly presented in cyst wall of
metacercariae and tegument of adult worm. In addition, para-
myosin was reported to exist predominantly in the tegument in non-
filamentous form, this property is of particular importance in the
design of new vaccines against a number of helminthes such as
schistosomes [36,37]. The immunomodulatory function of para-
myosin during helminth infection and its surface localization have
encouraged researchers to explore vaccine trials based on
paramyosin [19,38]. In our vaccine trials, CsPmy indeed exhibited
protective effect against C. sinensis challenge and induced combined
Th1/Th2 immune responses. Although the protective effect of
paramyosin has been validated in a variety of trematodes and
nematodes, the underlying mechanism remains to be clarified.
Regardingthe role ofparamyosin inthebiology of otherparasites, it
was suggested that protective effect of CsPmy could be resulted from
the inhibitive effect of high level and long-lasting strong circulating
antibodies on the muscle contraction and nutrition ingestion of C.
sinensis. Furthermore, during the constantly contact with immune
system of the host, paramyosin was also reported to perform non-
muscular functions in host-parasite interactions by binding IgG,
collagen and complement, which were related to the immune
evasion of parasites [17,39,40]. Thus, further studies are required to
break down the immune evasion of C. sinensis to enhance the current
protective effect based on the physical and biological properties of
CsPmy, as well as other identified cyst wall proteins.
Moreover, our studies indicated that full-length sequence of
paramyosin was difficult to express in the usual prokaryotic
Figure 7. Antibody titers of IgG induced by CsPmy measured by ELISA. Briefly, 1 mg/well recombinant pET-26b-CsPmy protein was coated
on the plates and blocked with 5% skimmed milk. The plate was incubated with different dilutions of the immune sera (week 6) raised by pET-26b-
CsPmy and pcDNA-CsPmy. Rat sera immunized with PBS and pcDNA were measured under the same conditions as negative controls. HRP-conjugated
IgG (1:20000 dilutions) was used as the secondary antibodies. The reactions were developed with substrate solution TMB, stopped by 2 M H2SO4 and
measured at measured at 450 nm. (A) Antibody titers of IgG induced by pET-26b-CsPmy. (B) Antibody titers of IgG induced by pcDNA-CsPmy.
doi:10.1371/journal.pone.0033703.g007
Figure 8. IgG isotype induced by CsPmy measured by ELISA. 1 mg/well recombinant pET-26b-CsPmy protein was coated on the plates and
blocked with 5% skimmed milk. Immune sera from week 2 to week 6 were diluted at 1:400. Rat sera immunized with PBS and pcDNA were measured
under the same conditions as negative controls. IgG (1:20000 dilutions), IgG1 and IgG2a (1:1000 dilutions) were used as secondary antibodies. (A)
Immune responses induced by pET-26b-CsPmy. (B) Immune responses induced by pcDNA-CsPmy.
doi:10.1371/journal.pone.0033703.g008
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prokaryotic expressing vectors including pET-28a(+), pET-30a(+),
pET-32a(+), pGEX-4T-1 and pQE-30 (see Figure S3). However,
no recombinant protein was detected in E. coli using these
expression plasmids (data not shown). Expression of CsPmy finally
succeed in vector pET-26b(+) as inclusion bodies (Figure 3), the
expression and purification of full-length sequence of CsPmy
enabled us to evaluate paramyosin as a potential vaccine candidate
as well as its biological properties in the future.
In conclusion, we have identified paramyosin from cyst wall of
C. sinensis metacercariae by proteomic approaches and investigated
the expression pattern in different life stages of C. sinensis.
Moreover, we have explored the potential role of CsPmy as a
protective vaccine candidate against C. sinensis infection. Further-
more, we developed Western blot analysis to investigate the
antigenicity of CsPmy in C. idellus since CsPmy was identified from
C. sinensis metacercariae which inhabited in C. idellus. As expected,
CsPmy was probed by both the serum and the mucus of infected C.
idellus (Figure S4). Coupled with our previous studies [41], vaccine
trials with CsPmy carried out in rats encouraged us to develop
vaccines in freshwater fish to combat cercarie infection by
inhibiting cyst wall formation.
Supporting Information
Figure S1 Nucleotide sequences and amino acid se-
quences of CsPmy from our laboratory (C. s-1) and
Korea (C. s-2). The full-length complete sequence of CsPmy
contains 3465 bp with an ORF (in red) of 2595 bp encoding 864
aa. Nucleotide and amino acid sequences described in the present
study have been submitted to GenBank database under the
accession number JQ041818. There are six base pairs and four
amino acids differences between C. s-1 and C. s-2 (shaded in
green). Five peptides (in blue) identified from HPLC-MS/MS
matched with both C. s-1 and C. s-2 with the protein coverage of
6.5% (56/864). (A) Nucleotide sequence of C. s-1. (B) Amino acid
sequence of C. s-1. (C) Nucleotide sequence of C. s-2. (D) Amino
acid sequence of C. s-2.
(TIF)
Figure S2 Cytokine production in spleen cells. To
evaluate cytokine production levels in immunized rats, the
production of Th1/Th2-associated cytokines in splenocytes
including Th1 type cytokine IFN-c and Th2 type cytokine IL-4
were measured to evaluate the immune responses induced by
CsPmy. Splenocytes were isolated from spleens of two rats in each
group before challenge. The cells were washed three times with
sterile PBS and treated with Erythrocyte Lysing Solution (Sigma)
to remove red blood cells, then 5610
5 cells/well were cultured
in 200 ml RPMI 1640 medium (Gibco, California, USA)
supplemented with 10% FBS, 1% penicillin, and 1% streptomy-
cin. Cytokine production of splenocytes was stimulated by TWE
(50 mg/ml), rPmy protein (50 mg/ml), or medium alone as control.
The 96-well plate (Corning, New York, USA) was maintained in
an incubator at 37uCi n5 %C O 2 for 72 h. Cell-free supernatants
were harvested and assayed for IFN-c and IL-4 with ELISA kits
(R&D Systems, Minneapolis, USA) according to the manufactur-
er’s instruction. All assays were performed in duplicate. The
concentration of IFN-c and IL-4 calculated by using a linear-
regression equation obtained from standard absorbance values. In
contrast to control groups, both IFN-c secretion (A) and IL-4
secretion (B) were induced by pET-26b-CsPmy and pcDNA-
CsPmy when corresponding splenocytes were stimulated by TWE
(p,0.01) or CsPmy (p,0.01).
(TIF)
Figure S3 Recombinant plasmids of CsPmy in different
prokaryotic expression vectors. 1, 2 and 3 were PCR
product of CsPmy, digestion of recombinant plasmid containing
CsPmy and digestion of the corresponding blank plasmid,
respectively. (A) Identification of recombinant pET-28a(+)-CsPmy
with restriction enzymes. (B) Identification of recombinant pET-
30a(+)-CsPmy with restriction enzymes. (C) Identification of
recombinant pET-32a(+)-CsPmy with restriction enzymes. (D)
Identification of recombinant pGEX-4T-1-CsPmy with restriction
enzymes. (E) Identification of recombinant pQE-30-CsPmy with
restriction enzymes. (F) Identification of recombinant pET-26b(+)-
CsPmy with restriction enzymes.
(TIF)
Figure S4 Immune responses to CsPmy in serum and
mucus of C. sinensis-infected C. idellus. As a cyst wall
protein of metacercariae which dwell in freshwater fish, we
investigated the antigenicity of CsPmy in the host C. idellus. (A)
Western blot analysis of antigenicity. Briefly, the recombinant
CsPmy (5 mg/lane) was subjected to SDS-PAGE (8% gel) and
electrotransferred onto polyvinylidene difluoride (PVDF, What-
man, Maidstone, United Kingdom) membrane, the membrane
was blocked with 5% (w/v) skim milk in phosphate buffered saline
(PBS, pH 7.4) at 4uC overnight. The membrane was subsequently
cut into strips then incubated with infected serum (1:20 dilutions in
1% BSA-PBS) or undiluted infected mucus. Naı ¨ve serum and
mucus were simultaneously incubated with the strips at room
temperature for 2 h. Rabbit anti-fish HRP-conjugated secondary
antibody (purchased from Chinese Academy of Medical Sciences)
was reacted with strips in the dilution of 1:1000 at room
temperature for 2 h. Diaminobenzidine (DAB) substrate solution
was used to visualize the reactions. As a result, we found that the
recombinant CsPmy could probe serum (lane 1) and mucus (lane 3)
from infected C. idellus while no reactions were found in naı ¨ve
Table 2. Protective effect of in vaccination trials
a.
Group Worm burden Worm reduction rate (%) EPG Egg reduction rate (%)
PBS (n=6) 27.867.3 3733.36467.6
pcDNA (n=6) 25.567.8 4466.761150.1
rPmy (n=6) 12.763.3
** 54.30% 1833.36542.8
** 50.90%
pcDNA-Pmy (n=6) 16.362.6
** 36.10% 2733.36546.5
** 38.80%
aProtective effect was assessed by comparing the worm burden and EPG between pET-26b-CsPmy group and PBS group, as well as pcDNA-CsPmy group and pcDNA
group, respectively. Results for analysis represented mean 6 S.D., and the recovered worm numbers and EPG in groups were compared by Student’s t-test.
(*)p,0.05 and.
(**)p,0.01 (compared to corresponding control).
doi:10.1371/journal.pone.0033703.t002
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PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e33703serum (lane 2) and mucus (lane 4). (B) ELISA assay of antibody
titers. The infected serum, naı ¨ve serum, infected mucus and naı ¨ve
mucus of C. idellus were gradiently diluted from 1:1 to 1:640,
experiment protocols for ELISA were the same as described in
Materials and Methods section. Although the level of circulated
antibody was low and the immune response was relatively weak,
ELISA assay showed antibody titers of IgM in serum and mucus
reached to 1:320, indicating that CsPmy could induce immune
response in C. idellus which was the intermediate host.
(TIF)
Table S1 Specific primers used in the present study.
(DOC)
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